Literature DB >> 7527157

Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein.

D Jackson1, O V Volpert, N Bouck, D I Linzer.   

Abstract

In many mammalian species, the placenta is the site of synthesis of proteins in the prolactin and growth hormone family. Analysis of two such proteins, proliferin (PLF) and proliferin-related protein (PRP), revealed that they are potent regulators of angiogenesis; PLF stimulated and PRP inhibited endothelial cell migration in cell culture and neovascularization in vivo. The mouse placenta secretes an angiogenic activity during the middle of pregnancy that corresponds primarily to PLF, but later in gestation releases a factor that inhibits angiogenesis, which was identified as PRP. Incubation of placental tissue with PLF led to the specific binding of this hormone to capillary endothelial cells. Thus PLF and PRP may regulate the initiation and then the cessation of placental neovascularization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527157     DOI: 10.1126/science.7527157

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  47 in total

Review 1.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

2.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

3.  Role of the composite glucocorticoid response element in proliferin gene expression.

Authors:  M A Hoeppner; J C Mordacq; D I Linzer
Journal:  Gene Expr       Date:  1995

4.  The rat prolactin gene family locus: species-specific gene family expansion.

Authors:  S M Khorshed Alam; Rupasri Ain; Toshihiro Konno; Jennifer K Ho-Chen; Michael J Soares
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

5.  Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression.

Authors:  D J Toft; S B Rosenberg; G Bergers; O Volpert; D I Linzer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.

Authors:  A Jonas Ekstrand; Renhai Cao; Meit Bjorndahl; Susanne Nystrom; Ann-Cathrine Jonsson-Rylander; Hessameh Hassani; Bengt Hallberg; Margareta Nordlander; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

Review 7.  Mannose metabolism: more than meets the eye.

Authors:  Vandana Sharma; Mie Ichikawa; Hudson H Freeze
Journal:  Biochem Biophys Res Commun       Date:  2014-06-12       Impact factor: 3.575

8.  Targets of tyrosine nitration in diabetic rat retina.

Authors:  Xianquan Zhan; Yunpeng Du; John S Crabb; Xiaorong Gu; Timothy S Kern; John W Crabb
Journal:  Mol Cell Proteomics       Date:  2007-12-28       Impact factor: 5.911

9.  Magnetic resonance imaging of hypoxic injury to the murine placenta.

Authors:  Tracy M Tomlinson; Joel R Garbow; Jeff R Anderson; John A Engelbach; D Michael Nelson; Yoel Sadovsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

10.  Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.

Authors:  Vandana Sharma; Jonamani Nayak; Charles DeRossi; Adriana Charbono; Mie Ichikawa; Bobby G Ng; Erika Grajales-Esquivel; Anand Srivastava; Ling Wang; Ping He; David A Scott; Joseph Russell; Emily Contreras; Cherise M Guess; Stan Krajewski; Katia Del Rio-Tsonis; Hudson H Freeze
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.